Cargando…
Impact of diagnostic delay on seizure outcome in newly diagnosed focal epilepsy
OBJECTIVE: In the current study, we aimed to assess the diagnostic delay and the impact of diagnostic delay on seizure outcome in a cohort of newly diagnosed patients with focal epilepsy. METHODS: The study material was compiled from eight clinical antiseizure medication monotherapy trials conducted...
Autores principales: | Parviainen, Laura, Kälviäinen, Reetta, Jutila, Leena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733655/ https://www.ncbi.nlm.nih.gov/pubmed/33336131 http://dx.doi.org/10.1002/epi4.12443 |
Ejemplares similares
-
Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
por: Yamamoto, Takamichi, et al.
Publicado: (2020) -
Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study
por: Trinka, Eugen, et al.
Publicado: (2020) -
Etiology, syndrome diagnosis, and cognition in childhood‐onset epilepsy: A population‐based study
por: Sokka, Arja, et al.
Publicado: (2017) -
Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?
por: Zaccara, Gaetano, et al.
Publicado: (2018) -
Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil
por: Gupta, Shaloo, et al.
Publicado: (2017)